Poolbeg Pharma PLC

OTCPK:POLB.F Stock Report

Mkt Cap: US$44.5m

Poolbeg Pharma Management

Management criteria checks 0/4

Key information

Jeremy Skillington

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO

Jeremy Skillington

1.8yrs

Tenure

Dr. Jeremy Skillington, Ph D., serves as Chief Executive Officer and since July 19, 2021 as Director at Poolbeg Pharma PLC. He is Vice President of Business Development at Inflazome Ltd.Dr. Skillington se...

Board Members

NamePositionTenureCompensationOwnership
Jeremy Skillington
CEO & Director1.8yrsno datano data
Ian O'Connell
CFO & Director2yrsno data1.67%
£ 741.7k
Patrick Ashe
Independent Non-Executive Director1.8yrsno data0.053%
£ 23.4k
Luke O'Neill
Independent Non-Executive Director & Member of Scientific Advisory Board1.8yrsno datano data
Brendan Buckley
Member of Scientific Advisory Boardless than a yearno datano data
Cathal Friel
Chairman of The Board2.2yrsno data4.19%
£ 1.9m
Elaine Sullivan
Member of Scientific Advisory Boardno datano datano data
Edward Gibson
Independent Non-Executive Director1.8yrsno datano data
Daniel Hoft
Member of Scientific Advisory Board1.5yrsno datano data

1.8yrs

Average Tenure

60yo

Average Age

Experienced Board: POLB.F's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.